No
The document does not mention AI, ML, or any related technologies in the device description or intended use. The focus is on standard ultrasound imaging capabilities and hardware features.
No
The device is described as a "general purpose diagnostic ultrasound system" intended for "ultrasound imaging, measurement, display and analysis," and "fluid flow analysis." Its purpose is to evaluate the body, not to provide therapy.
Yes
The "Intended Use / Indications for Use" and "Device Description" sections explicitly state that the Venue Go is a "general purpose diagnostic ultrasound system."
No
The device description explicitly details hardware components such as a compact, portable system with a high-resolution color LCD monitor, transducers, an internal battery, and capabilities for physical attachment to a cart or wall. It is a physical ultrasound system, not solely software.
Based on the provided information, the Venue Go is not an In Vitro Diagnostic (IVD) device.
Here's why:
- IVD Definition: In Vitro Diagnostic devices are used to examine specimens (like blood, urine, or tissue) taken from the human body to provide information about a person's health. This testing is done outside the body (in vitro).
- Venue Go's Function: The Venue Go is a diagnostic ultrasound system. It uses sound waves to create images of the inside of the human body directly (in vivo). It does not analyze specimens taken from the body.
- Intended Use: The intended use clearly states it's for "ultrasound imaging, measurement, display and analysis of the human body and fluid." This describes an in vivo imaging process, not in vitro testing of specimens.
Therefore, the Venue Go falls under the category of a diagnostic imaging device, not an In Vitro Diagnostic device.
N/A
Intended Use / Indications for Use
The Venue Go is a general purpose diagnostic ultrasound system for use by qualified and trained healthcare professionals or practitioners that are legally authorized or licensed by law in the country, state or other local municipality in which he or she practices, for ultrasound imaging, measurement, display and analysis of the human body and fluid. The users may or may not be working under supervision or authority of a physician. Users may also include medical students working under the supervision or authority of a physician during their education / training. Venue Go is intended to be used in a hospital or medical clinic. Venue Go clinical applications include: abdominal (GYN and Urology), thoracic/pleural, ophthalmic, Fetal/OB, Small Organ (including breast, testes, thyroid), Vascular/Peripheral vascular, neonatal and adult cephalic, pediatric, musculoskeletal (conventional and superficial), cardiac (adults and pediatric), Transrectal, Transvaginal, Transesophageal, Intraoperative (vascular) and interventional guidance (includes tissue biopsy, fluid drainage, vascular and non-vascular access). Modes of operation include: B, M, PW Doppler, CW Doppler, Color Doppler, Color M Doppler, Power Doppler, Harmonic Imaging, Coded Pulse and Combined modes: B/M, B/Color M, B/PWD, B/Color/PWD, B/Power/PWD, B/CWD, B/Color/CWD.
Product codes (comma separated list FDA assigned to the subject device)
IYN, IYO, ITX
Device Description
Venue Go is a general-purpose diagnostic ultrasound system intended for use by qualified and trained healthcare professionals to evaluate the body by ultrasound imaging and fluid flow analysis.
The Venue Go is a compact, portable system with a small footprint. The system can be hand carried using an integrated handle, placed on a horizontal surface, attached to a mobile cart or wall mounted. It has a high resolution color LCD monitor, with a simple, multi-touch user interface that makes the system intuitive. The system can be powered through an electrical wall outlet for long term use or from an internal battery for a short time with full functionality and scanning.
The Venue Go utilizes a variety of linear, convex, and phased array transducers which provide high imaging performance and support standard acquisition modes. Compatible biopsy kits can be used for needle-guidance procedures.
The system is capable of displaying the patient's ECG trace synchronized to the scanned image. This allows the user to view an image from a specific time of the ECG signal which is used as an input for gating during scanning. The ECG signal can be input directly from the patient or as an output from an ECG monitoring device. ECG information is not intended for monitoring or diagnosis.
A barcode reader and RFID scanner are available as additional input devices. A roller bag will also be available for the customer to use when transporting the system.
Venue Go is capable of wireless communication through a built-in Wireless LAN device. The system meets DICOM requirements to support image storage and archiving (local PACS or products such as Q-Path) and allows for output to printing devices.
Mentions image processing
Yes
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Ultrasound
Anatomical Site
abdominal (GYN and Urology), thoracic/pleural, ophthalmic, Fetal/OB, Small Organ (including breast, testes, thyroid), Vascular/Peripheral vascular, neonatal and adult cephalic, pediatric, musculoskeletal (conventional and superficial), cardiac (adults and pediatric), Transrectal, Transvaginal, Transesophageal, Intraoperative (vascular)
Indicated Patient Age Range
neonatal, pediatric, adults
Intended User / Care Setting
qualified and trained healthcare professionals or practitioners that are legally authorized or licensed by law in the country, state or other local municipality in which he or she practices. Users may or may not be working under supervision or authority of a physician. Users may also include medical students working under the supervision or authority of a physician during their education / training.
Intended to be used in a hospital or medical clinic.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The subject of this premarket submission, Venue Go, did not require clinical studies to support substantial equivalence.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
K231301, K161047, K231989, K180374, K202035, K200851, K203677, K201992
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 892.1550 Ultrasonic pulsed doppler imaging system.
(a)
Identification. An ultrasonic pulsed doppler imaging system is a device that combines the features of continuous wave doppler-effect technology with pulsed-echo effect technology and is intended to determine stationary body tissue characteristics, such as depth or location of tissue interfaces or dynamic tissue characteristics such as velocity of blood or tissue motion. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.(b)
Classification. Class II.
0
June 10, 2024
Image /page/0/Picture/1 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: the Department of Health & Human Services logo on the left and the FDA text logo on the right. The FDA text logo is in blue and includes the words "FDA U.S. FOOD & DRUG ADMINISTRATION" stacked on top of each other.
GE Medical Systems Ultrasound and Primary Care Diagnostics % Karin Shimoni Regulatory Affairs Manager 9900 Innovation Drive WAUWATOSA WI 53226
Re: K240053
Trade/Device Name: Venue Go Regulation Number: 21 CFR 892.1550 Regulation Name: Ultrasonic Pulsed Doppler Imaging System Regulatory Class: Class II Product Code: IYN, IYO, ITX Dated: January 8, 2024 Received: May 9, 2024
Dear Karin Shimoni:
We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device" (https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download).
1
Your device is also subject to, among other requirements, the Quality System (QS) regulation (21 CFR Part 820), which includes, but is not limited to, 21 CFR 820.30, Design controls; 21 CFR 820.90, Nonconforming product; and 21 CFR 820.100, Corrective and preventive action. Please note that regardless of whether a change requires premarket review, the QS regulation requires device manufacturers to review and approve changes to device design and production (21 CFR 820.30 and 21 CFR 820.70) and document changes and approvals in the device master record (21 CFR 820.181).
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Yanna S. Kang -S
Yanna Kang, Ph.D. Assistant Director Mammography and Ultrasound Team DHT8C: Division of Radiological Imaging and Radiation Therapy Devices OHT8: Office of Radiological Health Office of Product Evaluation and Quality Center for Devices and Radiological Health
2
Indications for Use
| Submission Number (if known) | K240053 |
|---|---|
| Device Name | Venue Go |
| Indications for Use (Describe) | The Venue Go is a general purpose diagnostic ultrasound system for use by qualified and trained healthcare professionals or practitioners that are legally authorized or licensed by law in the country, state or other local municipality in which he or she practices, for ultrasound imaging, measurement, display and analysis of the human body and fluid. The users may or may not be working under supervision or authority of a physician. Users may also include medical students working under the supervision or authority of a physician during their education / training. Venue Go is intended to be used in a hospital or medical clinic. Venue Go clinical applications include: abdominal (GYN and Urology), thoracic/pleural, ophthalmic, Fetal/OB, Small Organ (including breast, testes, thyroid), Vascular/Peripheral vascular, neonatal and adult cephalic, pediatric, musculoskeletal (conventional and superficial), cardiac (adults and pediatric), Transrectal, Transvaginal, Transesophageal, Intraoperative (vascular) and interventional guidance (includes tissue biopsy, fluid drainage, vascular and non-vascular access). Modes of operation include: B, M, PW Doppler, CW Doppler, Color Doppler, Color M Doppler, Power Doppler, Harmonic Imaging, |
Coded Pulse and Combined modes: B/M, B/Color M, B/PWD, B/Color/PWD, B/Power/PWD,
B/CWD, B/Color/CWD.
Type of Use (Select one or both, as applicable)
Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
Image /page/3/Picture/1 description: The image shows the logo for GE HealthCare. The logo consists of a circular emblem with the letters "GE" inside, followed by the text "GE HealthCare". The text is written in a simple, sans-serif font and is aligned to the right of the emblem. The color of the logo is a shade of purple.
510(k) Summary - K240053
| Date: | January 08, 2024 |
|---|---|
| Submitter: | GE Medical Systems Ultrasound and Primary Care Diagnostics |
| 9900 Innovation Drive | |
| Wauwatosa, WI 53226 | |
| Primary Contact Person: | Karin Shimoni |
| Regulatory Affairs Manager | |
| GE HealthCare | |
| T: (+972) 546347710 | |
| Secondary Contact Person: | Lee Bush |
| Regulatory Affairs Director | |
| GE HealthCare | |
| T: (262) 3099429 | |
| Device Trade Name: | Venue Go |
| Common/Usual Name: | Diagnostic Ultrasound System |
| Classification Names: | Class II |
| Product Code: | Ultrasonic Pulsed Doppler Imaging System. 21CFR 892.1550 90- |
| IYN; Ultrasonic Pulsed Echo Imaging System, 21CFR 892.1560 | |
| 90-IYO; Diagnostic Ultrasound Transducer, 21 CFR 892.1570, | |
| 90-ITX | |
| Primary Predicate Device: | K220800 Venue Go, Diagnostic Ultrasound System |
| Classification Names: | Class II |
| Product Code: | Ultrasonic Pulsed Doppler Imaging System. 21CFR 892.1550 90- |
| IYN; Ultrasonic Pulsed Echo Imaging System, 21CFR 892.1560 | |
| 90-IYO; Diagnostic Ultrasound Transducer, 21 CFR 892.1570, | |
| 90-ITX |
4
Image /page/4/Picture/1 description: The image shows the logo for GE HealthCare. The logo consists of a purple circular emblem with intertwined "GE" letters on the left. To the right of the emblem, the text "GE HealthCare" is written in purple, with "GE" slightly larger than "HealthCare".
GE HealthCare
510(k) Premarket Notification Submission
| Reference Device(s):
Classification Names:
Product Code: | K231301 Vscan Air
Class II
Ultrasonic Pulsed Doppler Imaging System. 21CFR 892.1550 90-
IYN; Ultrasonic Pulsed Echo Imaging System, 21CFR 892.1560,
90-IYO: Diagnostic Ultrasound Transducer, 21 CFR 892.1570.
90-ITX |
|----------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Reference Device(s):
Classification Names:
Product Code: | K161047 LOGIQ P9 and LOGIQ P7
Class II
Ultrasonic Pulsed Doppler Imaging System. 21CFR 892.1550 90-
IYN; Ultrasonic Pulsed Echo Imaging System, 21CFR 892.1560,
90-IYO; Diagnostic Ultrasound Transducer, 21 CFR 892.1570,
90-ITX |
| Reference Device(s):
Classification Names:
Product Code: | K231989 LOGIQ E10s/LOGIQ Fortis
Class II
Ultrasonic Pulsed Doppler Imaging System. 21CFR 892.1550 90-
IYN; Ultrasonic Pulsed Echo Imaging System, 21CFR 892.1560,
90-IYO; Diagnostic Ultrasound Transducer, 21 CFR 892.1570,
90-ITX |
| Reference Device(s):
Classification Names:
Product Code: | K180374 Voluson S8/ Voluson S10/ Voluson S10 Expert
Class II
Ultrasonic Pulsed Doppler Imaging System. 21CFR 892.1550 90-
IYN; Ultrasonic Pulsed Echo Imaging System, 21CFR 892.1560,
90-IYO; Diagnostic Ultrasound Transducer, 21 CFR 892.1570,
90-ITX |
| Reference Device(s):
Classification Names:
Product Code: | K202035 Vscan Air
Class II
Ultrasonic Pulsed Doppler Imaging System. 21CFR 892.1550 90-
IYN; Ultrasonic Pulsed Echo Imaging System, 21CFR 892.1560,
90-IYO; Diagnostic Ultrasound Transducer, 21 CFR 892.1570,
90-ITX |
| Reference Device(s):
Classification Names:
Product Code: | K200851 Vivid T8, Vivid T9
Class II
Ultrasonic Pulsed Doppler Imaging System. 21CFR 892.1550 90-
IYN; Ultrasonic Pulsed Echo Imaging System, 21CFR 892.1560,
90-IYO; Diagnostic Ultrasound Transducer, 21 CFR 892.1570,
90-ITX |
5
Image /page/5/Picture/1 description: The image shows the logo for GE HealthCare. The logo consists of a circular emblem on the left and the text "GE HealthCare" on the right. The emblem is a stylized, swirling design, and the text is in a clean, sans-serif font, both in a matching purple color.
| Reference Device(s):
Classification Names:
Product Code: | K203677 ViewPoint 6
Class II
Picture archiving and communications system, 21 CFR 892.2050, 90-LLZ |
|----------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Reference Device(s):
Classification Names:
Product Code: | K201992 Caption Guidance
Class II
QJU |
| Device Description: | Venue Go is a general-purpose diagnostic ultrasound system intended for use by qualified and trained healthcare professionals to evaluate the body by ultrasound imaging and fluid flow analysis.
The Venue Go is a compact, portable system with a small footprint. The system can be hand carried using an integrated handle, placed on a horizontal surface, attached to a mobile cart or wall mounted. It has a high resolution color LCD monitor, with a simple, multi-touch user interface that makes the system intuitive. The system can be powered through an electrical wall outlet for long term use or from an internal battery for a short time with full functionality and scanning.
The Venue Go utilizes a variety of linear, convex, and phased array transducers which provide high imaging performance and support standard acquisition modes. Compatible biopsy kits can be used for needle-guidance procedures.
The system is capable of displaying the patient's ECG trace synchronized to the scanned image. This allows the user to view an image from a specific time of the ECG signal which is used as an input for gating during scanning. The ECG signal can be input directly from the patient or as an output from an ECG monitoring device. ECG information is not intended for monitoring or diagnosis.
A barcode reader and RFID scanner are available as additional input devices. A roller bag will also be available for the customer to use when transporting the system.
Venue Go is capable of wireless communication through a built-in Wireless LAN device. The system meets DICOM requirements to support image storage and archiving (local PACS or products such as Q-Path) and allows for output to printing devices. |
6
Image /page/6/Picture/1 description: The image shows the GE HealthCare logo. The logo consists of a circular emblem with stylized letters inside, followed by the text "GE HealthCare" in a simple, sans-serif font. The emblem and text are both in a matching shade of purple.
Intended Use: The Venue Go is a general purpose diagnostic ultrasound system for use by qualified and trained healthcare professionals or practitioners that are legally authorized or licensed by law in the country, state or other local municipality in which he or she practices, for ultrasound imaging, measurement, display and analysis of the human body and fluid. The users may or may not be working under supervision or authority of a physician. Users mav also include medical students working under the supervision or authority of a physician during their education / training. Venue Go is intended to be used in a hospital or medical clinic. Venue Go clinical applications include: abdominal (GYN and Urology), thoracic/pleural, ophthalmic, Fetal/OB, Small Organ (including breast, testes, thyroid), Vascular/Peripheral vascular, neonatal and adult cephalic, pediatric, musculoskeletal (conventional and superficial), cardiac (adults and pediatric), Transrectal, Transvaginal, Transesophageal, Intraoperative (vascular) and interventional guidance (includes tissue biopsy, fluid drainage, vascular and non-vascular access). Modes of operation include: B, M, PW Doppler, CW Doppler, Color Doppler, Color M Doppler, Power Doppler, Harmonic Imaging, Coded Pulse and Combined modes: B/M, B/Color M, B/PWD, B/Color/PWD, B/Power/PWD, B/CWD, B/Color/CWD. Re. Technology: The Venue Go employs the same fundamental scientific technology as its predicate and reference devices. Determination of Comparison to Predicate Device Substantial Equivalence: The Venue Go system is substantially equivalent to the predicate device with regards to imaging capabilities, technological characteristics and safety and effectiveness. All probes used with the proposed Venue Go system are used unchanged from the cleared predicate. They are made of the same materials and their shape is unchanged. The following is an overview of the differences between the proposed Venue Go and the predicate Venue Go: Indications for Use: The proposed Venue Go and predicate Venue Go (K220800) have similar clinical indications for use, however the IFU statement is updated to add details to the operator qualification/profile for clarity. No change to the product and no impact to safe or effective use. The proposed Venue Go and predicate Venue Go (K220800) have identical imaging modes.
7
Image /page/7/Picture/1 description: The image contains the GE HealthCare logo. The logo consists of a circular emblem on the left and the text "GE HealthCare" on the right. The emblem is a stylized, circular design in purple. The text "GE HealthCare" is also in purple and is written in a clean, sans-serif font.
Transducers:
The proposed Venue Go and predicate Venue Go (K220800) systems transducers are similar, except for
- Addition of C2-9-RS which was first cleared on Voluson ● S8/ Voluson S10/ Voluson S10 Expert K180374. This probe is unchanged from the cleared reference device (K180374). It is made of the same materials and its shape is unchanged. The clinical indications of C2-9-RS are the same on the proposed Venue Go as they are on the reference device LOGIQ E10s/LOGIQ Fortis K231989 with C2-9-D probe. The C2-9-RS probe is the same as the C2-9-D except it uses an RS connector instead of a D connector. The transducer body is identical between the two.
- . Addition of Vscan Air CL and SL probes. The Vscan Air CL was first cleared in K202035 and the Vscan Air SL was first cleared in K231301. The clinical indications of the Vscan Air CL and SL are identical as on the reference device Vscan Air K231301. The Vscan Air CL probe is cleared also on reference LOGIO E10s/LOGIO Fortis K231989.
- Addition of neonatal cephalic application on existing L10-● 22-RS probe. This application was already cleared with this probe on reference device LOGIQ P9 and LOGIQ P7 (K161047).
- Addition of PDI+ on existing ML6-15-RS probe (both imaging mode and probe are cleared on predicate Venue Go (K220800).
Features/Functionality:
- Vscan Air CL and Vscan Air SL probes: The proposed ● Venue Go system supports the Vscan Air CL and Vscan Air SL cleared in K231301. The Vscan Air CL probe is cleared also on reference LOGIQ E10s/LOGIQ Fortis K231989.
- . Auto Volume Flow (AVF): The AVF tool is a semiautomated tool intended to measure inflow in the vessel. It enables the user to perform a quick assessment, especially when measuring inflow in the artery of the fistula of a dialysis patient. The rate of volume flow is calculated using pulsed wave (PW) Doppler flow measurement.
- Bladder Volume Tool: Bladder Volume Tool provides a ● simplified workflow for bladder volume measurement.
8
Image /page/8/Picture/1 description: The image shows the GE HealthCare logo. The logo consists of the GE monogram enclosed in a circular frame on the left, followed by the text "GE HealthCare" on the right. The logo and text are both in a purple color.
GE HealthCare
510(k) Premarket Notification Submission
- . MSK diagrams The MSK Diagram enables documenting and summarizing MSK exam in an anatomical view. On predicate Venue Go K220800, the only diagram that was available for MSK preset was the shoulder diagram. On the proposed Venue Go, diagrams are also added for the knee, wrist/hand, hip, elbow and ankle/foot.
- . Venue Coach: Venue Coach contains all the diagrams and reference images available in the proposed Venue Go system. From the Venue Coach tab, user can configure a diagram, a reference image or both.
- Electronic delivery of SW: The proposed Venue Go . system now allows the user, in addition to service personnel, to update the SW by logging into a GEHC website to download SW available to them and install it on the system.
- . Expanding cleared Auto Inferior Vena Cava (IVC), Auto B-Lines, Real Time ejection fraction (RT-EF) and cNerve for Vscan Air CL and SL probes. These probes are already cleared on predicate Vscan Air K231301. The Vscan Air CL probe is cleared also on reference device LOGIQ E10s/LOGIQ Fortis K231989.
- AppAPI functionality: to facilitate future integration of ● multiple software components.
Hardware:
When Vscan Air CL and SL probes are to be used with the proposed Venue Go system, then the cart on proposed Venue Go is updated to include an optional connectivity solution that allows wireless connectivity with the Vscan Air CL and SL probes and provides power for the wireless charger.
Summary of Non-Clinical Tests:
The proposed Venue Go has been evaluated for acoustic output, biocompatibility, cleaning and disinfection effectiveness as well as thermal, electrical, electromagnetic, and mechanical safety, and has been found to comply with applicable medical device safety standards. The Venue Go complies with voluntary standards:
- . Marketing Clearance of Diagnostic Ultrasound Systems and Transducers - Guidance for Industry and Food and Drug Administration Staff, issued on February 21, 2023
- AAMI/ANSI ES60601-1, Medical Electrical Equipment -● Part 1: General Requirements for Safety, 2005/ A2:2021
9
Image /page/9/Picture/1 description: The image shows the GE HealthCare logo. The logo consists of a circular emblem on the left and the text "GE HealthCare" on the right. The emblem is purple and has a stylized design. The text is also purple and is written in a sans-serif font.
GE HealthCare
510(k) Premarket Notification Submission
- IEC 60601-1-2, Medical Electrical Equipment Part 1-2: . General Requirements for Safety - Collateral Standard: Electromagnetic Compatibility Requirements and Tests, 2020
- IEC 60601-2-37, Medical Electrical Equipment Part 2-● 37: Particular Requirements for the Safety of Ultrasonic Medical Diagnostic and Monitoring Equipment, 2015
- IEC 62359. Ultrasonics Field characterization Test . methods for the determination of thermal and mechanical indices related to medical diagnostic ultrasonic fields, 2017
- ISO 10993-1, Biological Evaluation of Medical Devices-● Part 1: Evaluation and Testing Within a Risk Management Process, Fifth edition, 2018
- ISO 14971, Application of risk management to medical ● devices, 2019
- . NEMA PS 3.1 - 3.20e, Digital Imaging and Communications in Medicine (DICOM) Set, 2021
- AAMI TIR69, Technical Information Report Risk . management of radio-frequency wireless coexistence for medical devices and systems, 2020
The following quality assurance measures are applied to the development of the system:
- Risk Analysis
- Requirements Reviews ●
- Design Reviews ●
- Testing on unit level (Module verification) ●
- Integration testing (System verification)
- Performance testing (Verification & Validation)
- Safety testing (Verification) .
Transducer material and other patient contact materials are biocompatible.
Summary of Clinical Tests:
The subject of this premarket submission, Venue Go, did not require clinical studies to support substantial equivalence.
10
Image /page/10/Picture/1 description: The image shows the GE HealthCare logo. The logo consists of a circular emblem on the left and the text "GE HealthCare" on the right. The emblem is a stylized representation of the letters "GE" within a circle, and the text is in a clean, sans-serif font.
Based on the equipment design similarities, conformance to Conclusion: recognized performance standards, and performance testing, GE HealthCare considers the proposed Venue Go to be as safe, Effective, and performs in a substantially equivalent manner as the predicate Venue Go (K220800).